Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Research & Development
Theravance Biopharma Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Research & Development
-$40.6m
|
CAGR 3-Years
46%
|
CAGR 5-Years
27%
|
CAGR 10-Years
10%
|
See Also
What is Theravance Biopharma Inc's Research & Development?
Research & Development
-40.6m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Research & Development amounts to -40.6m USD.
What is Theravance Biopharma Inc's Research & Development growth rate?
Research & Development CAGR 10Y
10%
Over the last year, the Research & Development growth was 36%. The average annual Research & Development growth rates for Theravance Biopharma Inc have been 46% over the past three years , 27% over the past five years , and 10% over the past ten years .